Metrics as of 10/17/2026, 07:43 AM (Berlin time), refresh in progress.
Zimmer Biomet Holdings Stock
Zimmer Biomet Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Ivan Tornos
- Employees
- 17,000
- Market cap
- $18.1 B
- IPO
- 25/07/2001
Zimmer Biomet Holdings, Inc. is a healthcare company operating in the medical devices industry. Founded by Justin O. Zimmer in 1927, the firm is headquartered in Warsaw, Indiana. The company engages in the design, manufacture, and marketing of orthopedic reconstructive products. Its extensive portfolio also includes…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Zimmer Biomet Holdings stock: price history
1D
+0.6%
1W
+6.6%
1M
-1.9%
6M
+0.2%
YTD
+5.6%
1Y
-4.9%
2Y
-9.9%
5Y
-33.1%
10Y
-23.0%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~71% stronger price swings than usual
Zimmer Biomet Holdings stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Zimmer Biomet Holdings
Analyst assessment of Zimmer Biomet Holdings
PRICE TARGET LOW
US$93.00
CONSENSUS
US$103.11
MEDIAN
US$104.00
PRICE TARGET HIGH
US$120.00
0
STRONG BUY
17
BUY
22
HOLD
3
SELL
0
STRONG SELL
42
TOTAL · Hold
As of: 10/08/2026
Zimmer Biomet Holdings stock metrics
P/E
23
P/B
1.45
EV/EBITDA
10.78
RETURN ON EQUITY
1.6%
NET MARGIN
9.1%
DEBT/EQUITY
0.59
DIVIDEND YIELD
1.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.8%
FLOAT SHARES
190,403,636
AVG. DAILY VOLUME (30D)
2,132,792
Insider transactions (SEC)
Campbell Gary Craig
Campbell Gary Craig
Campbell Gary Craig
Campbell Gary Craig
Thornal Kevin R
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Zimmer Biomet Holdings stock
What does Zimmer Biomet Holdings do?
Zimmer Biomet Holdings, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Ivan Tornos, the company employs around 17,000 people.
The IPO was on 25/07/2001; the stock trades on NYSE under the ticker ZBH.
What do analysts say about Zimmer Biomet Holdings stock?
42 analysts rate the stock, the consensus is Hold (as of 10/08/2026).
The average price target is US$103.11, ranging from US$93.00 to US$120.00, with a median of US$104.00.
This is an external assessment, not a statement by Market Jury.
When does Zimmer Biomet Holdings report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 71% stronger than usual.
Does Zimmer Biomet Holdings pay a dividend?
Yes. The last dividend was US$0.24 per share, ex-date 30/09/2026, paid on 30/10/2026.
The dividend yield is 1.0% (as of 30/06/2026).
Which stocks are comparable to Zimmer Biomet Holdings?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Align Technology and Bio-Rad Laboratories.
How can I get Zimmer Biomet Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Zimmer Biomet Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.